trending Market Intelligence /marketintelligence/en/news-insights/trending/7gu-dxa_uuv2fqoinptpaq2 content esgSubNav
In This List

Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.

The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.

Corporate Stock Transfer Inc. is acting as exchange agent for the split.